Showing results (2201-2210 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|November 11, 2008
Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?Manuela Iero, Paola Filipazzi, Chiara Castelli, et al.
Cancer Immunology, Immunotherapy : CII|November 20, 2008
Peroxisome proliferator-activated receptor gamma overexpression and knockdown: impact on human B cell lymphoma proliferation and survivalTatiana M Garcia-Bates, Scott A Peslak, Carolyn J Baglole, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearersL M Weiskirch, B A Baumgartel, E Barker, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Cytochalasin-B-induced immunosuppression of murine allogeneic anti-tumor response and the effect of recombinant human interleukin-2D Bogyo, S R Fondy, L Finster, et al.
Cancer Immunology, Immunotherapy : CII|August 28, 2007
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)Sylvia Janetzki, Katherine S Panageas, Leah Ben-Porat, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2007
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer developmentJovanny Zabaleta, Barbara G Schneider, Kelli Ryckman, et al.
Cancer Immunology, Immunotherapy : CII|July 10, 2007
New T cell epitopes identified from an anti-idiotypic antibody mimicking ovarian cancer associated antigenWei Li, Heng Cui, Fan-Qiang Meng, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2007
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaAkash M Mehta, Ekaterina S Jordanova, Gemma G Kenter, et al.
Cancer Immunology, Immunotherapy : CII|July 12, 2007
HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for preventionMalcolm Taylor, Christine Harrison, Tim Eden, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2007
Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c miceNikola Baschuk, Olaf Utermöhlen, Roland Gugel, et al.
Pageof 652